Background Image
Previous Page  13 / 99 Next Page
Information
Show Menu
Previous Page 13 / 99 Next Page
Page Background

T

reatment

of

brain

metastases

R

ev

A

ssoc

M

ed

B

ras

2016; 62(5):389-394

393

for those not treated with radiotherapy

vs.

9.5 months for

patients undergoing RT (95CI 7.8-11.9), p=0.71 (level of

evidence

1B

).

Aoyama et al. (1996) did not find benefit in function-

al prognosis (p=0.53) or preservation of neurological func-

tion (p=0.99) at 12 months with combined treatment (lev-

el of evidence

1B

).

Evidence summary

Radiotherapy combined with holocranial radiotherapy does

not increase the time of functional independence com-

pared with radiosurgery

(A)

. However, compared to patients

treated with radiotherapy, the combined treatment is supe-

rior in terms of functional independence at 6 months

(B)

.

O

utcome

: T

umor

control

4) C

linical

question

Does radiosurgery combined with holocranial radiother-

apy improve tumor control compared with radiosurgery

or holocranial radiotherapy alone?

Results

The study by Kondziolka et al. (1997) ended prematurely

after an interim analysis identified considerable benefit in

terms of local tumor control with combined treatment

compared to radiotherapy alone. The median time to lo-

cal recurrence was 36 months for the first and 6 months

for radiotherapy alone (p=0.005) (level of evidence

2B

).

In the study by Kocher et al. (2004), combined treat-

ment led to better local control of tumors at 2 years com-

pared with radiosurgery alone: reduction from 31% (95CI

22-40%) to 19% (95CI 11-27%; p=0.04). There was also bet-

ter control of tumors in other locations: a reduction from

48% (95CI 38-58%) to 33% (95CI 24-43%; p=0.023).

In the study by Chang et al. (2009), tumor control at

1 year occurred in 100% of the patients undergoing com-

bined treatment

versus

67% of tumor control with radio-

surgery alone (p=0.012).

In the study by Aoyama et al. (1996), tumor control

at 12 months reached 88.7% (95CI 80.1-97.3%) in the

group of combined treatment

versus

72.5% (95CI 60.3-

84.7%) in the group undergoing radiosurgery alone

(p=0.002). Tumor control at 1 year in other sites of the

brain was also more favorable than under combined treat-

ment. There was a decline from 73% to 45% (p=0.02).

Evidence summary

Radiosurgery combined with holocranial radiotherapy

reduces the likelihood of local tumor recurrence and the

development of new brain lesions

(A)

.

O

utcome

: C

ognitive

decline

5) C

linical

question

Is radiosurgery combined with holocranial radiotherapy

associated with greater cognitive decline compared with

radiosurgery or holocranial radiotherapy alone?

Results

The study by Chang et al. (2009) had cognitive function as

the primary endpoint, which was evaluated by a set of neu-

ropsychological tests covering various domains. This study

was terminated early after an interim analysis demonstrat-

ed that the possibility of deterioration of learning andmem-

ory at 4 months was significantly higher in patients under-

going combined treatment (52%) than in patients treated

with radiosurgery alone (24%) (level of evidence

1B

).

Aoyama et al.

13

(2007) used the mini-mental state ex-

amination to assess cognitive function, and found that

the main factor related to cognitive function is tumor

control. Cognitive worsening was earlier the single treat-

ment group (7.6 months

vs.

16.5 months, p=0.05). How-

ever, after 36 months, only 14.7% of patients who under-

went combined treatment had no cognitive worsening

(level of evidence

2B

).

Evidence summary

Radiosurgery combined with holocranial radiotherapy

leads to significant worsening of cognition compared

with radiosurgery alone

(A)

.

O

utcome

: Q

uality

of

life

6) C

linical

question

Is radiosurgery combined with holocranial radiotherapy

associated with poorer quality of life compared to radio-

surgery or holocranial radiotherapy alone?

Results

Soffietti et al. (2013) analyzed the aspects of quality of

life based on the EORTC QLQ-C30 scale in patients un-

dergoing radiosurgery/surgery alone or combined treat-

ment. Patients who underwent combined treatment had

poorer overall quality of life at 9 months (p=0.014) (lev-

el of evidence

2B

).

Evidence summary

Radiosurgery combined with holocranial radiotherapy is

associated with poorer quality of life

(B)

.

N

ote

The different treatment modalities, either combined or

alone, produce different effects on various outcomes. The